Clinical Trials
Imperial College London to begin human testing of new Covid-19 vaccine
The study will be the first time Imperial’s vaccine has been trialled in humans and will assess whether it is well-tolerated and produces an...
Drug Research
Cobra signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate
Cobra Biologics, part of the Cognate BioServices family, an international CDMO for biologics and pharmaceuticals, announced it has signed a supply agreement with AstraZeneca...
Drug Research
Neurocrine and Takeda Ink $2 Billion-Plus Neuroscience Development Deal
San Diego-based Neurocrine Biosciences is partnering with Japan’s Takeda Pharmaceutical to develop and commercialize molecules in Takeda’s early-to-mid-stage psychiatry pipeline. Takeda granted an exclusive...
Press Releases
Jazz Pharma Gets Approval for Zepzelca in the U.S. for Aggressive Lung Cancer
The U.S. FDA approved Jazz Pharmaceuticals and its partner PharmaMar’s Zepzelca (lurbinectedin) for adults with metastatic small cell lung cancer (SCLC) whose disease has...
Drug Research
Saiba AG Selects AGC Biologics to Develop and Produce COVID-19 Vaccine
AGC Biologics, a global biopharmaceutical Contract Development Manufacturing Organization (CDMO), has announced it will be partnering with Saiba AG to manufacture a SARS-CoV-2 vaccine...
Clinical Trials
Eli Lilly Begins Phase III Study of RA Drug to Treat COVID-19
Eli Lilly will assess its JAK1/JAK2 inhibitor Olumiant (baricitinib) as a potential treatment for COVID-19 in a Phase III study.
Indianapolis-based Eli Lilly said the...
Clinical Trials
Atyr Pharma Announces Dosing Of First Patient In Phase 2 Trial Of ATYR1923 In Covid-19 Patients
aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, announced that it has...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read